Abstract：There is increasing experimental and epidemiological evidence that many kinds of endocrine disrupting chemicals (EDCs) are contributing to metabolic syndrome. Exposure to EDCs associated with occurrence of type 2 diabetes, hypertension, obesity, polycystic ovary syndrome based on recent studies. EDCs interfere with normal functions of endocrine system which has mimic estrogenic effect mostly.producingdevelopmental,reproductive,neurological,cardiovascular,metabolic and immune effectin humans.Human expose to EDCs via consuming food, taking breathe, skin absorption in daily life whichin include bisphenol,nonyphenol,phthalates,Dixons and the likes,polychlorinated biphenyls mainly. This review focused on bisphenol A(BPA) actions of pothogenesy of type 2 diabetes, hypertension, obesity, PCOS and summarized outcomes of this field according to literatures native and abroad.
杨雪松, 许洁. 环境内分泌干扰物与代谢综合征关系研究进展[J]. 实用预防医学, 2016, 23(2): 247-249.
Yang Xue-song, Xu Jie. Research progress of relationship between bisphenol A and metabolic syndrome. , 2016, 23(2): 247-249.
[1] Li Jian, Ma Mei, Wang Zi-jian. Action mechanism and bioassays of environmental endocrine disrupting chemicals [J]. Environmental Monitoring and Forewarnming.2(3)(2010)18-25. [2] Meeker JD1. Exposure to environmental endocrine disrupting compouds and men's health [J] Maturitas 66(3)(2010)236-41 [3] Thaddeus T.Schug, Amanda Janesik, Bruce Blumberg,et al.Endocrine disrupting chemicals and disease susceptibility [J].Journal of Biochemistry ＆ Molecular Biology 127(2011)204-215. [4] Heindel JJ, Levin E. Developmental origins and environmental influences-introduction.NIEHS symposium. Birth Defects Res A Clin Mol Teratol 2005;73(7):469. [5] 宋顺吉,贾丽红.境刺激素对男性生殖细胞影响的研究进展[J]实用预防医学2013,20(10)1279-80 [6] 孙霞 , 林怡 , 董四君. 低剂量双酚 A 暴露与代谢综合征相关性的研究进展[J]. 环境与健康杂志 2012,29(9)853-7. [7] L.N. Vandenberg, I. Chauhoud, J.J. Heindel,et al . Urinary, circulating and tissue biomonitoring studies indicate widespread exposure to bisphenol A, Environ. Health Perspect. 118 (2010) 1055-70 [8] Janesick, A., Blumberg, B., 2011. Minireview: PPARgamma as the target of obesogens. J. Steroid Biochem. Mol. Biol. 147, 4-8. [9] Jones, M.E., Thorburn, A.W., Britt, K.L., et al. 2001.Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J. Steroid Biochem. Mol. Biol. 79, 3-9. [10] Jones, M.E., Thorburn, A.W., Britt, K.L., et al. 2001.Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J. Steroid Biochem. Mol. Biol. 79, 3-9. [11] King H, Aubert RE, Herman WH． Global burden of diabetes, 1995– 2025: prevalence, numerical estimates, and projections[J] ．Diabetes Care, 1998, 21 (9) : 1414 – 1431 [12] Lee DH,Lee IK,PortaM, etal .Relationship between serum concentrstions of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults results from the National Health and Nutrition Examination Survey1999-2002[J].Diabetologia 2007,50 1841-51 [13] Arsenescu V,Arsenescu RI,King V.Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflamatory adipokines and promotes obesity and atheroclerosis[J].Environ Health Perspect 2008,116(6):761-768 [14] Aston-Mourney K, Proietto J, Morahan G, et al． Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin[J].Diabetologia, 2008, 51 (4) : 540 – 545． [15] Alonso-Magdalena P, Laribi O, Ropero AB, et al． Low doses of bisphenol A and diethylstilbestrol impair Ca2 + signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans[J]. Environ Health Perspect,2005,113(8) : 969 – 977 [16] S. A. Polyzos, J. Kountouras, G. Deretzi, C. Zavos and C. S. Mantzoros. The Emerging Role of Endocrine Disruptors in Pathogenesis of Insulin Resistance: A Concept Implicating Nonalcoholic Fatty Liver Disease [J]. Current Molecular Medicine, 2012 Jan;12(1):68-82. [17] Regnier SM1, Kirkley AG, Ye H, E,et al. Dietary Exposure to the Endocrine Disruptor Tolylfluanid Promotes Global Metabolic Dysfunction in Male Mice[J].Endocinology.en 2014 1668 [18] March, W.A. et al. (2010) The prevalence of polycystic ovary syndrome in acommunity sample assessed under contrasting diagnostic criteria.Hum. Reprod. 25, 544-551 [19] Boyle, J.A. et al. (2012) Prevalence of polycystic ovary syndrome in a sample ofIndigenous women in Darwin. Aust. Med. J. Aust. 196, 62-66 [20] Yildiz, B.O. et al. (2012) Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.Hum. Reprod. 27, 3067-3073 [21] Barrett ES 1 , Sobolewski M 2 . Polycystic ovary syndrome: do endocrine disrupting chemicals play a role?[J].Semin Reprod Med. 2014 May;32(3):166-76 [22] 刘嘉茵 二届全国多囊卵巢综合征及其相关疾病诊治新进展专题研讨会2006-07-01 [23] Miyawaki J, Sakayama K, Kato H, et al． Perinatal andpostnataexposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice[J] ． J Ather Throm, 2007, 14: 245． [24] Wei J, Lin Y, Li Y, et al． Perinatal exposure to bisphenol A atreference dose predisposes offspring to metabolic syndrome in adult rats on a high–fat diet[J].Endocrinology, 2011, 152: 3049–3061． [25] Shankar A, Teppala S, Sabanayagam C． Bisphenol A and peripheraarterial disease: results from the NHANES[J] ． Environ Health Perspect,2012,doi:10.1289/ehp.1104114 [26] Ryan KK, Haller AM, Sorrell JE, et al． Perinatal exposure tobisphenol–a and the development of metabolic syndrome in CD–1 mice[J] ． Endocrinology, 2010, 151: 2603–261
2016, Vol. 23 
